Oncology

Research shows patients with vitiligo have no increased cancer risk, with reduced risks for melanoma, lung, and bladder cancers.

AI foundation models boost ovarian carcinoma subtyping accuracy, providing clinicians with valuable diagnostic support and efficiency.

A newly updated clinical practice guideline offers healthcare practitioners vital evidence-based recommendations for managing hepatitis B reactivation (HBVr) in individuals at risk.

A recent comprehensive study has offered new insights into the role of human epidermal growth factor 2 (HER2) in male breast cancer…

A recent study has revealed an increased risk of thyroid cancer diagnoses within the first year of starting GLP-1RA therapy.

A French study finds significant increases in digestive cancer risks, including small bowel, pancreatic, and gastric cancers, in celiac patients.

BRCA1/BRCA2 carriers face significantly higher risks of second cancers, including ovarian and pancreatic, after breast cancer.

A study suggests extending colonoscopy rescreening beyond 10 years for low-risk individuals, based on long-term colorectal cancer outcomes.